MoneyWorks4Me

Glenmark Pharmaceuticals board to consider Unaudited Financial Results

14 Jan 2014 Evaluate

Glenmark Pharmaceuticals has informed that a meeting of the Board of Directors of the company will be held on January 24, 2014, to consider and approve the Company Un-audited Financial Statements for the Third Quarter ended December 31, 2013.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..